InvestorsHub Logo
Followers 22
Posts 3749
Boards Moderated 0
Alias Born 05/15/2014

Re: None

Friday, 06/05/2020 8:04:39 AM

Friday, June 05, 2020 8:04:39 AM

Post# of 183013
ARCT: Arcturus Therapeutics Announces First Healthy Volunteer Dosed in Phase 1 Study of ARCT-810 for Ornithine Transcarbamylase (OTC) Deficiency
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.